CL Shortlisted For Four Awards

7th August 2018

Cure Leukaemia has been shortlisted in four categories in the prestigious Charity Times Awards.

The awards, now into their 19th year, reward excellence across 30 separate categories, celebrating best practice in the UK charity and not-for-profit sector.

The best individual charities and charity leaders will be celebrated, alongside the best examples of specific areas of charity management including fundraising, communications, campaigning and use of technology.

Cure Leukaemia has been nominated in the following categories: Charity of the Year (income of £1million-£5million); Fundraising Team of the Year; Financial Management Award.

CEO James McLaughlin, who last month won the West Midlands IOD Director of the Year (Third Sector) Award, is among the nominations for Charity Principal of the Year.

The recognition in landing the four nominations follows a record-breaking year in 2017 in which Cure Leukaemia broke through the £2million fundraising barrier for the first time, whilst still employing just five full time staff.

This success helped complete the funding required for the expansion of the globally significant Centre for Clinical Haematology at Birmingham’s Queen Elizabeth Hospital, and also secured two-year support from global company Deutsche Bank as one of its UK Charities of the Year.

Chairman of Cure Leukaemia Ian Allen said: “I am immensely proud that Cure Leukaemia has been shortlisted in four categories for such prestigious and industry-recognised awards.

“It is another reflection of the fantastic work being carried out day-in, day-out, by James and his dedicated team, to drive Cure Leukaemia forward in making global progress towards the eradication of this disease.

“Awards and nominations are never the motivation for this work, but it is recognition of the huge progress that the charity is making - and will continue to make - over the coming years.

“I would also like to take this opportunity to thank all of those who continue to underpin the team effort behind Cure Leukaemia, including our individual fundraisers, businesses and corporate sponsors and, above all, the incredible nurses and patients who inspire everyone connected with the charity.

“Your help and support is very much appreciated as we pursue Professor Charlie Craddock’s ambition of eradicating all forms of blood cancer within the next 25 years.”

The winners of the Charity Times awards will be announced at the Park Plaza Hotel at Westminster Bridge in London on 3 October.